Wendy R Muñoz-Montaño
5PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 26, 2024
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097-6110.Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño
|Sep 16, 2024
Combination of neutrophil-to-lymphocyte ratio and serum CA 19-9 as a prognostic factor in pancreatic cancer.Juan Sebastián García-Herrera, Wendy R Muñoz-Montaño, Horacio N López-Basave
|Dec 07, 2023
Taxanes for the treatment of breast cancer during pregnancy: an international cohort study.Ana S Ferrigno Guajardo, Bryan F Vaca-Cartagena, Erica L Mayer
|Jul 28, 2023
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer.Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño
|Dec 05, 2022
The Prognostic Significance of HALP Index for Colon Cancer Patients in a Hispanic-Based Population.German Calderillo Ruiz, Horacio Lopez Basave, Rafael Sebastian Vazquez Renteria
Pageof 1
Frequent Collaborators
2 joint publications
Horacio N López-Basave
2 joint publications
Oscar Arrieta
2 joint publications
Carolina Castillo-Morales
1 joint publications
Ana S Ferrigno Guajardo
1 joint publications
Fedro Peccatori
1 joint publications
Matteo Lambertini
1 joint publications
Karla F Hernández-Castañeda
1 joint publications
Luca Arecco
1 joint publications
Cynthia Villarreal-Garza
1 joint publications
German Calderillo Ruiz
